Cargando…
Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling
Autores principales: | Yang, Wen, Zheng, Zhikun, Yi, Pengfei, Wang, Shi, Zhang, Ning, Ming, Jie, Tan, Jie, Guo, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430396/ https://www.ncbi.nlm.nih.gov/pubmed/34513720 http://dx.doi.org/10.3389/fonc.2021.759471 |
Ejemplares similares
-
LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling
por: Yang, Wen, et al.
Publicado: (2020) -
Curcumin Regulates the Progression of Colorectal Cancer via LncRNA NBR2/AMPK
Pathway
por: Yu, Hua, et al.
Publicado: (2019) -
lncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress
por: Liu, Xiaowen, et al.
Publicado: (2016) -
lncRNA NBR2 attenuates angiotensin II-induced myocardial hypertrophy through repressing ER stress via activating LKB1/AMPK/Sirt1 pathway
por: Zhu, Cansheng, et al.
Publicado: (2022) -
Genomic Instability-Related LncRNA Signature Predicts the Prognosis and Highlights LINC01614 Is a Tumor Microenvironment-Related Oncogenic lncRNA of Papillary Thyroid Carcinoma
por: Dong, Xubin, et al.
Publicado: (2021)